Uwe Gottschalk

Operating Partner at
Keensight Capital and was previously Chief Scientific Officer at Lonza

Uwe Gottschalk is Chief Scientific Officer (CSO) at Lonza since July 2017. Between 2014 and 2017 he served as a Chief Technology Officer where he established and led the global Research and Technology organisation of Lonza Pharma/Biotech.